Low doses of Simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-Infected dogs.
Nenhuma Miniatura disponível
Data
2011
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Chagas cardiomyopathy remodeling is based on the presence of Trypanosoma cruzi in heart tissue and on
the complex inflammatory response leading to a myocardium fibrosis and alterations in conductive and functional heart
parameters. This study aims to evaluate Simvastatin on the inflammatory response and heart functionality using dogs
infected with Y strain of T. cruzi . Animals were treated daily with Simvastatin (20 mg) for 6 months and submitted to clinical
and immunopathological evaluations. Simvastatin reduced heart expression and serum levels of interferon-γ (IFN-γ)
and tumor necrosis factor-α (TNF-α) but not interleukin-10 (IL-10), possibly favoring blood parasitism but reducing
inflammation and fibrosis in the left ventricle and right atrium. Simvastatin also ameliorated ejection fraction, diastolic
diameter, and mass index of the left ventricle 6 months after infection. This study suggests that more investigation should
be performed on the use of statins as a prophylactic therapy against cardiac remodeling because of their effects on modifying
immune response and benefiting functional parameters in dogs with T. cruzi -induced ventricular dysfunctions.
Descrição
Palavras-chave
Citação
MELO, L. et al. Low doses of Simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-Infected dogs. The American Journal of Tropical Medicine and Hygiene, v. 84, p. 325-331, 2011. Disponível em: <http://www.ajtmh.org/content/84/2/325>. Acesso em: 19 fev. 2017.